Company / FCF Margin
Inhibikase Therapeutics, Inc. FCF Margin History
FY2022-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-6947.9%
FY2024
5-year range
-14253.4% / -461.1%
FY2022-FY2024
Trend
+51.3%
vs FY2023
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from -461.1% to -6947.9% over the past 2 years.
Based on SEC 10-K filings.
-6947.9% in FY2024.
Declined from -461.1% to -6947.9% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2024, fcf margin increased 51.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -6947.9% | +51.3% |
| FY2023 | -14253.4% | -2991.1% |
| FY2022 | -461.1% | - |
| FY2021 | - | - |
As of FY2024 · SEC 10-K · Updated Jun 24, 2026